4-phenylbutyric acid has been researched along with pyrazolanthrone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammerpohl, O; Griep, U; Grutzmann, R; Janssen, O; Kalthoff, H; Kloppel, G; Pilarsky, C; Saeger, HD; Schniewind, B; Sipos, B; Trauzold, A | 1 |
Chauvin, MA; Croze, ML; Géloën, A; Guichardant, M; Koppe, L; Pesenti, S; Pillon, NJ; Rieusset, J; Soulage, CO; Vella, RE; Zarrouki, B | 1 |
2 other study(ies) available for 4-phenylbutyric acid and pyrazolanthrone
Article | Year |
---|---|
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
Topics: Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Caspase 8; Cell Communication; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Gap Junctions; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Pancreatic Neoplasms; Phenylbutyrates; Time Factors; Tumor Cells, Cultured | 2007 |
Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal kinase activation.
Topics: Acetylcysteine; Animals; Anthracenes; Bronchoalveolar Lavage Fluid; Cell Line; Enzyme Activation; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Mice; Ozone; Phenylbutyrates; Rats | 2015 |